Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: Vaccine potential and protein expression

Microbial Cell Factories

Volumn 15, Issue 1, 2016, Pages

  Santana Jorge, Karina T O ^a   Santos, Túlio M ^a,b   Tartaglia, Natayme R ^a   Aguiar, Edgar L ^a   Souza, Renata F S ^a   Mariutti, Ricardo B ^c   Eberle, Raphael J ^c   Arni, Raghuvir K ^c   Portela, Ricardo W ^d   Meyer, Roberto ^d   Azevedo, Vasco ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Uniclon Biotecnologia   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Corynebacterium pseudotuberculosis; Epitope prediction; Pathogenicity and virulence; Protein expression; Protein purification; Vaccine potential

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN NANH; PROTEIN PKNG; PROTEIN SODC; PROTEIN SPAC; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL VACCINE; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER MODEL; CONTROLLED STUDY; CORYNEBACTERIUM PSEUDOTUBERCULOSIS; ESCHERICHIA COLI; HETEROLOGOUS EXPRESSION; HUMORAL IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; T LYMPHOCYTE; BIOSYNTHESIS; CLUSTER ANALYSIS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PLASMID; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; BACTERIAL VACCINES; CLUSTER ANALYSIS; CORYNEBACTERIUM PSEUDOTUBERCULOSIS; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; ESCHERICHIA COLI; GENE EXPRESSION; MOLECULAR SEQUENCE DATA; PLASMIDS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; VIRULENCE FACTORS;

EID: 85007426086     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/s12934-016-0479-6     Document Type: Article

References (57)

1. Dorella FA, Pacheco LGC, Oliveira SC, Miyoshi A, Azevedo V. Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res. 2006;37:201-18.
2. de Sá Guimarães A, do Carmo FB, Pauletti RB, Seyffert N, Ribeiro D, Lage AP, et al. Caseous lymphadenitis: epidemiology, diagnosis, and control. IIOAB J. 2011;2:33-43.
3. Baird GJ, Fontaine MC. Corynebacterium pseudotuberculosis and its role in Ovine Caseous Lymphadenitis. J Comp Pathol. 2007;137:179-210.
4. Fontaine MC, Baird GJ. Caseous lymphadenitis. Small Rumin Res. 2008;76:42-8.
5. Windsor PA. Control of caseous lymphadenitis. Vet Clin North Am-Food Anim Pract. 2011;27:193-202.
6. Oreiby AF. Diagnosis of caseous lymphadenitis in sheep and goat. Small Rumin Res. 2015;123:160-6.
7. Bastos BL, Dias Portela RW, Dorella FA, Ribeiro D, Seyffert N, et al. Corynebacterium pseudotuberculosis: immunological responses in animal models and zoonotic potential. J Clin Cell Immunol. 2012;S4:005. doi:10.4172/2155-9899.S4-005
8. Trost E, Ott L, Schneider J, Schröder J, Jaenicke S, Goesmann A, et al. The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence. BMC Genom. 2010;11:728.
9. Rogers EA, Das A, Ton-That H. Adhesion by pathogenic corynebacteria. Adv Exp Med Biol. 2011;715:91-103.
10. Kim S, Oh DB, Kang HA, Kwon O. Features and applications of bacterial sialidases. Appl Microbiol Biotechnol. 2011;91:1-15.
11. Kim S, Oh DB, Kwon O, Kang HA. Identification and functional characterization of the NanH extracellular sialidase from Corynebacterium diphtheriae. J Biochem. 2010;147:523-33.
12. Dussurget O, Stewart G, Neyrolles O, Pescher P, Young D, Marchal G. Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase. Infect Immun. 2001;69:529-33.
13. Piddington DL, Fang FC, Laessig T, Cooper M, Orme IM, Buchmeier NA, et al. Cu, Zn Superoxide Dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst cu, zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages. Infect Immun. 2001;69:4980-7.
14. Pereira SFF, Goss L, Dworkin J. Eukaryote-like serine/threonine kinases and phosphatases in bacteria. Microbiol Mol Biol Rev. 2011;75:192-212.
15. Forrellad MA, Klepp LI, Gioffré A, Sabio y García J, Morbidoni HR, de la Paz Santangelo M, et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013;4:3-66.
16. Walburger A, Koul A, Ferrari G, Nguyen L, Prescianotto-Baschong C, Huygen K, et al. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science. 2004;304:1800-4.
17. Warner DF, Mizrahi V. The survival kit of Mycobacterium tuberculosis. Nat Med. 2007;13:282-4.
18. Altschul SF, Gish W, Pennsylvania T, Park U. Basic local alignment search tool 2Department of computer science. J Mol Biol. 1990;215:403-10.
19. Consortium TU. UniProt: a hub for protein information. Nucleic Acids Res. 2014;43:D204-12.
20. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. Protein identification and analysis tools on the ExPASy server. Proteomics protocols handbook. New York City: Humana Press; 2005. p. 571-607.
21. Geourjon C, Deléage G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci. 1995;11:681-4.
22. Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics. 2010;26:1608-15.
23. Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011;8:785-6.
24. Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4.
25. El-Manzalawy Y, Honavar V. Recent advances in B-cell epitope prediction methods. Immunome Res. London: BioMed Central Ltd; 2010;6:S2.
26. Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci. 1988;4:181-6.
27. Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol. 1985;55:836-9.
28. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157:105-32.
29. White A, Handler P, Smith EL, editors. Principles of Biochemistry. 3rd ed. 1964.
30. Rini JM, Schulze-Gahmen U, Wilson IA. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science. 1992;255:959-65.
31. Chou BPY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol. 1978;47:45-148.
32. Chou PY. Prediction of protein structural classes from amino acid composition. Predict Protein Struct Princ Protein Conform. 1989;549-86.
33. Karplus PA, Schulz GE. Prediction of chain flexibility in proteins synthesis of acetylcholine receptors in xenopus oocytes induced by poly (A)+-mRNA from locust nervous tissue. Naturwissenschaften. 1985;72:2-3.
34. Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, et al. CDD: NCBI's conserved domain database. Nucleic Acids Res. 2015;43:D222-6.
35. Saha S, Saha S, Raghava GPS, Raghava GPS. Prediction methods for B-cell epitopes. Methods Mol Biol. 2007;409:387-94.
36. Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 2015;43:D405-12.
37. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui H-H, et al. A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nat Biotechnol. 2006;24:817-9.
38. Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinform. 2009;10:296.
39. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega. Mol Syst Biol. 2011;7:539.
40. Sambrook J, Russell DW, editors. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2001.
41. Welch M, Govindarajan S, Ness JE, Villalobos A, Gurney A, Minshull J, et al. Design parameters to control synthetic gene expression in Escherichia coli. PLoS One. 2009;4:e7002.
42. Saïda F, Uzan M, Odaert B, Bontems F. Expression of highly toxic genes in E. coli: special strategies and genetic tools. Curr Protein Pept Sci. 2006;7:47-56.
43. Arnon R. A novel approach to vaccine design-pitope-based vaccines. FEBS J. 2006;273:33-4.
44. Grimm SK, Ackerman ME. Vaccine design: emerging concepts and renewed optimism. Curr Opin Biotechnol. 2013;24:1078-88.
45. Trivedi S, Gehlot HS, Rao SR. Protein thermostability in archaea and eubacteria. Genet Mol Res. 2006;5:816-27.
46. Goodswen SJ, Kennedy PJ, Ellis JT. A guide to in silico vaccine discovery for eukaryotic pathogens. Brief Bioinform. 2013;14:753-74.
47. Bhavsar AP, Guttman JA, Finlay BB. Manipulation of host-cell pathways by bacterial pathogens. Nature. 2007;449:827-34.
48. Krachler AM, Orth K. Targeting the bacteria-host interface. Virulence. 2013;4:284-94.
49. Kaufmann SHE, Hess J. Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development. Immunol Lett. 1999;65:81-4.
50. De Arruda LB, Chikhlikar PR, August JT, Marques ETA. DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response. Immunology. 2004;112:126-35.
51. Kimura K, Kimura D, Matsushima Y, Miyakoda M, Honma K, Yuda M, et al. CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection. Infect Immun. 2013;81:3825-34.
52. McKean S, Davies J, Moore R. Identification of macrophage induced genes of Corynebacterium pseudotuberculosis by differential fluorescence induction. Microbes Infect. 2005;7:1352-63.
53. Lan DT, Taniguchi S, Makino S, Shirahata T, Nakane A. Role of endogenous tumor necrosis factor alpha and gamma interferon in resistance to Corynebacterium pseudotuberculosis infection in mice. Microbiol Immunol. 1998;42:863-70.
54. Lan DT, Makino S, Shirahata T, Yamada M, Nakane A. Tumor necrosis factor alpha and gamma interferon are required for the development of protective immunity to secondary Corynebacterium pseudotuberculosis infection in mice. J Vet Med Sci. 1999;61:1203-8.
55. Chakraborty S, Chakravorty R, Ahmed M, Rahman A, Waise TZ, Hassan F, et al. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions. In Silico Biol. 2010;10:235-46.
56. Dudek NL, Perlmutter P, Aguilar M-I, Croft NP, Purcell AW. Epitope discovery and their use in peptide based vaccines. Curr Pharm Des. 2010;16:3149-57.
57. Sugiki T, Fujiwara T, Kojima C. Latest approaches for efficient protein production in drug discovery. Expert Opin Drug Discov. 2014;1-16.